Literature DB >> 11588469

N-acetylcysteine increases cerebral perfusion pressure in pigs with fulminant hepatic failure.

L M Ytrebø1, C Korvald, G I Nedredal, O P Elvenes, O J Nielsen Grymyr, A Revhaug.   

Abstract

OBJECTIVE: Intravenous administration of N-acetylcysteine beyond 15 hrs reduces mortality rates in patients suffering from paracetamol-induced fulminant hepatic failure, although the mechanism of the therapeutic benefit remains unclear. We hypothesized increased survival to be caused by improved hemodynamic performance. The main objective for the study was to explore the effect of N-acetylcysteine on hemodynamics, oxygen transport, and regional blood flow in pigs with fulminant hepatic failure.
DESIGN: Prospective, randomized, controlled trial.
SETTING: Surgical research laboratory in a university hospital.
SUBJECTS: Female Norwegian Landrace pigs.
INTERVENTIONS: Fulminant hepatic failure was induced by a total liver devascularization procedure. Five hours later, the pigs were allocated to N-acetylcysteine treatment (150 mg.kg-1 in 100 mL of 0.9% saline over 15 mins, followed by 50 mg.kg-1 in 500 mL of 0.9% saline over a period of 4 hrs) or placebo.
MEASUREMENTS AND MAIN RESULTS: Mean arterial pressure stabilized in the N-acetylcysteine group and increased slightly during the last 2 hrs (pGT =.009). Thus, mean arterial pressure was significantly higher compared with placebo after 3 hrs (p =.01). Cerebral perfusion pressure was significantly higher during the last 2 hrs in the N-acetylcysteine group (pGT =.033). Common carotid artery flow also increased and was maintained at a higher level compared with placebo (pG =.027). Systemic vascular resistance index initially decreased but then gradually increased (pGT <.001). Cardiac index increased after 15 mins of N-acetylcysteine infusion, causing a significant interaction (pGT =.038), but did not differ after 3 hrs. No significant differences in hindleg and mesentery hemodynamics were found. A short-lived increase in oxygen delivery caused by a temporary increase in cardiac index was observed but without any corresponding increase in oxygen consumption.
CONCLUSIONS: Intravenous N-acetylcysteine infusion increases cerebral perfusion pressure in pigs with fulminant hepatic failure. Earlier reported effects on oxygen transport and uptake could not be confirmed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588469     DOI: 10.1097/00003246-200110000-00023

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

Review 1.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 2.  Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.

Authors:  Dominic R Aldridge; Edward J Tranah; Debbie L Shawcross
Journal:  J Clin Exp Hepatol       Date:  2014-06-30

3.  Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failure.

Authors:  Vikram Sharma; Gabriella A M Ten Have; Lars Ytrebo; Sambit Sen; Christopher F Rose; R Neil Dalton; Charles Turner; Arthur Revhaug; Hans M H van-Eijk; Nicolaas E P Deutz; Rajiv Jalan; Rajeshwar P Mookerjee; Nathan A Davies
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

4.  Effect of N-Acetylcysteine on Mortality and Liver Transplantation Rate in Non-Acetaminophen-Induced Acute Liver Failure: A Multicenter Study.

Authors:  Samar K Darweesh; Mona F Ibrahim; Mahmoud A El-Tahawy
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

Review 5.  An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.

Authors:  María-Jesús Tuñón; Marcelino Alvarez; Jesús-M Culebras; Javier González-Gallego
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

Review 6.  [Acute liver failure].

Authors:  K Rifai; M J Bahr
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

7.  Brain creatine kinase activity is inhibited after hepatic failure induced by carbon tetrachloride or acetaminophen.

Authors:  Gustavo S Pacheco; Jordana P Panatto; Diego A Fagundes; Giselli Scaini; Cintia Bassani; Isabela C Jeremias; Gislaine T Rezin; Larissa Constantino; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2009-08-18       Impact factor: 3.584

8.  Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation.

Authors:  Khalid Mumtaz; Zahid Azam; Saeed Hamid; Shahab Abid; Sadik Memon; Hasnain Ali Shah; Wasim Jafri
Journal:  Hepatol Int       Date:  2009-08-29       Impact factor: 6.047

Review 9.  Pathophysiology of cerebral oedema in acute liver failure.

Authors:  Teresa R Scott; Victoria T Kronsten; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 10.  Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.

Authors:  Yuanyuan Jin; Haixia Wang; Ke Yi; Shixian Lv; Hanze Hu; Mingqiang Li; Yu Tao
Journal:  Nanomicro Lett       Date:  2020-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.